New drug aims to shrink hard-to-treat tumors in 30-patient trial
Disease control
Recruiting now
This study tests an experimental drug called IMC-001 in 30 adults whose advanced solid tumors have a high number of genetic mutations (TMB-H). The main goal is to see if the drug can shrink tumors. Researchers will also monitor side effects and how long the drug keeps the cancer …
Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC